| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0693ed4f2b7b1fab97515ac2f1f311c |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-496
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D239-94 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D239-94
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-517
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 |
| filingDate |
2014-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f375ec125ce983a8ad728e55ed82e49a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dbb9c1a28f041a8dfac66f75747bee10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85e9e8f101f5836f7b2f8af113f7bc82
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a80341144bc12d709432335429c9dbbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b6d41c94ea2557ff0bdbfaffef47986d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a2f02be82e5fe3287adb8b8a6b88196d |
| publicationDate |
2016-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-105503746-A |
| titleOfInvention |
Compounds for promoting apoptosis of cancer cells, pharmaceutical compositions and uses thereof |
| abstract |
The invention discloses a compound for promoting cancer cell apoptosis, its pharmaceutical composition and application. Specifically, the present invention provides a compound of formula (I) or a salt thereof, Wherein, m is an integer ranging from 2 to 7, and R is independently selected from at least one of the group consisting of hydrogen and C 1 -C 20 alkyl. The compound is used to promote the apoptosis of cancer cells to inhibit the growth of cancer cells. The present invention further provides a pharmaceutical composition comprising a compound of formula (I) or a salt thereof and a pharmaceutically acceptable carrier. The present invention further provides a use of a compound comprising formula (I) or a salt thereof for the manufacture of a medicament for treating cancer. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9980967-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111303129-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111303129-B |
| priorityDate |
2014-09-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |